v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended 167 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Revenue          
Sales         $ 2,994,931
Cost of sales         3,325,639
Gross Loss         (330,708)
Operating Expenses          
Depreciation         52,694
Market development 155,049 421,801 239,425 633,515 897,940
Selling, general and administration 199,810 145,565 617,315 615,452 13,139,469
Product development 142,744 77,031 368,150 220,927 3,792,165
Professional fees 22,937 21,379 92,250 122,897 1,982,655
Total Operating Expenses 520,540 665,776 1,317,140 1,592,791 19,864,923
Operating Loss (520,540) (665,776) (1,317,140) (1,592,791) (20,195,631)
Other Expenses (Income)          
Interest 272,292 375,425 3,403,966 2,776,138 21,714,793
Loss on write-off equipment         36,623
Other expenses (income)     (39,900)   266,224
Total Other Expenses 272,292 375,425 3,364,066 2,776,138 22,017,640
Net Loss $ (792,832) $ (1,041,201) $ (4,681,206) $ (4,368,929) $ (42,213,271)
Net loss per share, basic and diluted (in Dollars per share) $ 0.00 $ 0.00 $ (0.02) $ (0.02)  
Weighted average shares outstanding, - basic and diluted (in Shares) 224,087,799 213,977,909 217,347,872 213,977,909